Radioiodine dispensing and usage in a centralized hospital nuclear pharmacy

Thyroid

Volumn 7, Issue 2, 1997, Pages 289-294

  Hung, Joseph C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

DRUG DISPOSITION; DRUG USE; HUMAN; PHARMACY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; THYROID DISEASE;

EID: 0030971862     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.289     Document Type: Review

References (31)

1. Howard BY 1979 Safe handling of radioiodinated solutions. J Nucl Med Technol 4:28-30.
2. Croft BY 1979 Safe handling of radioiodine. J Nucl Med Technol 20:362-363 (letter).
3. Kowalsky RJ, Perry LR 1987 Chemistry of radiopharmaceuticals. In: Kowalsky RJ, Perry LR (eds) Radiopharmaceuticals in nuclear medicine practice. Appleton & Lange, Norwalk, Connecticut, pp. 75-95.
4. Wolfangel RG 1979 Reply. J Nucl Med Technol 20:995 (letter).
5. Luckett LW, Stotler RE 1980 Radioiodine volatilization from reformulated sodium iodide I-131 oral solution. J Nucl Med 21:477-479.
6. Haney TA, Wedeking P, Morcos N, Loberg MD 1981 A therapeutic and diagnostic I-131 capsule formulation with minimal volatility and maximal bioavailability. J Nucl Med 22:P74 (abstract).
7. Kowalsky RJ, Perry LR 1987 Chemistry, handling procedures, and precautions of radioiodine. In: Kowalsky RJ, Perry LR (eds) Radiopharmaceuticals in nuclear medicine practice. Appleton & Lange, Norwalk, Connecticut, pp. 181-210.
8. Grossman LW, Williams CC 1980 Chilling - an effective way of reducing volatility of therapeutic iodine solutions. J Nucl Med 21:P93 (abstract).
9. Miller KL, Bott SM, Velkley DE, Cunningham DE 1979 Review of contamination and exposure hazards association with therapeutic uses of radioiodine. J Nucl Med Technol 7:163-166.
10. 131I-natriumjodid-Gelatinkapseln für die Radiojod-Therapie. Nuc-Compact August: 148-152.
11. Clanton JA, Chilton HM, Laven DL, Slater JB, Strane TR 1989 Volatility of I-131 therapy solutions for oral administration: A multi-center study. Holker & Barry, Inc., Brooklyn, New York.
12. Hackett MT, Perdikaris N, Ruffin TT 1995 Additional radiation safety concerns involving sodium iodide-131 capsules. J Nucl Med Technol 23:289-290.
13. Ficken VJ 1996 Additional radiation safety concerns involving sodium iodide-131 capsules. J Nucl Med Technol 24:139 (letter).
14. Hackett MT 1996 Reply. J Nucl Med Technol 24:139-140 (letter).
15. 131I thyroid uptakes: Capsule versus liquid. J Nucl Med 14:507-510.
16. von Schulthess GK, Seelentag WW, Pfeiffer G, Blaeuenstein P, Bekier A 1985 131-Iodine capsules in thyroid therapy: An individually controlled study of their uptake kinetics as compared to liquid 131-iodine. Eur J Nucl Med 10:25-28.
17. 131I]sodium iodide capsules. Nucl Med Biol 16:491-493.
18. 131I]sodium iodide capsules. Nucl Med Biol 17:465-467.
19. Samyn JC, Jung WY 1970 In vitro dissolution from several experimental capsule formulations. J Pharm Sciences 59:169-175.
20. Newton JM, Rowley G, Tornblom J-FV 1971 The effect of additives on the release of drug from hard gelatin capsules. J Pharm Pharmac 23:452-453.
21. 131I) capsules. Nucl Med Commun 7:839-843.
22. 131I thyroid uptakes by incomplete dissolution of capsule filler. J Nucl Med 15:770-774.
23. Sodium iodide I 123 capsules 1995 In: The United States pharmacopeia, 23rd rev., and The national formulary, 18th ed. United States Pharmacopeial Convention, Rockville, Maryland, p. 818.
24. Sodium iodide I 131 capsules 1995 In: The United States Pharmacopeia, 23rd rev., and The national formulary, 18th ed. United States Pharmacopeial Convention, Rockville, Maryland, p. 822.
25. Hays MT, Solomon DH 1965 Influence of the gastrointestinal iodide cycle on the early distribution of radioactive iodide in man. J Clin Invest 44:117-127.
26. Bacterial endotoxins test 1995 In: The United States pharmacopeia, 23rd rev., and The national formulary, 18th ed. United States Pharmacopeial Convention, Rockville, Maryland, pp. 1696-1697.
27. Maguire WJ 1980 A precaution for minimizing radiation exposure from iodine vaporization. J Nucl Med Technol 8:90-93.
28. US Nuclear Regulatory Commission 1995 Possession, use, calibration, and check of dose calibrators. In: Code of Federal Regulations, Energy, 10 CFR Part 35.50. US Government Printing Office, Washington, DC, p. 537.
29. Oswald WM, Wilson ME, Hung JC 1991 Dose calibrator linearity testing: A new perspective. J Nucl Med Technol 19:122 (abstract).
30. Oswald WM, Herold TJ, Wilson ME, Hung JC 1992 Dose calibrator linearity testing using an improved attenuator system. J Nucl Med Technol 20:169-172.
31. US Nuclear Regulatory Commission 1991 Quality management program and misadministrations. In: Federal Register, 10 CFR Parts 2 and 35. US Government Printing Office, Washington, DC, pp. 34104-34122.